Form 8-K - Current report:
SEC Accession No. 0001628280-15-007208
Filing Date
2015-09-18
Accepted
2015-09-18 17:26:18
Documents
4
Period of Report
2015-09-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cumberlandandclinigen8k091.htm 8-K 27207
2 EXHIBIT 99.1 - PRESS RELEASE cumberlandandclinigen8k-01.htm EX-99.1 23521
3 clinigengroup.jpg GRAPHIC 8374
4 cumberlandpicturea02.jpg GRAPHIC 154951
  Complete submission text file 0001628280-15-007208.txt   276585
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 151116048
SIC: 2834 Pharmaceutical Preparations